- Home
- SPGC vs SLRX Comparison
SPGC vs SLRX Comparison
Compare SPGC & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPGC
- SLRX
- Stock Information
- Founded
- SPGC 2018
- SLRX N/A
- Country
- SPGC United States
- SLRX United States
- Employees
- SPGC N/A
- SLRX N/A
- Industry
- SPGC
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- SPGC
- SLRX Health Care
- Exchange
- SPGC Nasdaq
- SLRX Nasdaq
- Market Cap
- SPGC 2.6M
- SLRX 2.1M
- IPO Year
- SPGC 2023
- SLRX N/A
- Fundamental
- Price
- SPGC $0.66
- SLRX $1.34
- Analyst Decision
- SPGC
- SLRX
- Analyst Count
- SPGC 0
- SLRX 0
- Target Price
- SPGC N/A
- SLRX N/A
- AVG Volume (30 Days)
- SPGC 22.4M
- SLRX 71.1K
- Earning Date
- SPGC 03-17-2025
- SLRX 03-21-2025
- Dividend Yield
- SPGC N/A
- SLRX N/A
- EPS Growth
- SPGC N/A
- SLRX N/A
- EPS
- SPGC N/A
- SLRX N/A
- Revenue
- SPGC $2,491,000.00
- SLRX N/A
- Revenue This Year
- SPGC $912.03
- SLRX N/A
- Revenue Next Year
- SPGC $49.80
- SLRX N/A
- P/E Ratio
- SPGC N/A
- SLRX N/A
- Revenue Growth
- SPGC 840.00
- SLRX N/A
- 52 Week Low
- SPGC $0.26
- SLRX $1.22
- 52 Week High
- SPGC $6.97
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- SPGC 51.47
- SLRX 32.32
- Support Level
- SPGC $0.35
- SLRX $2.08
- Resistance Level
- SPGC $1.34
- SLRX $1.94
- Average True Range (ATR)
- SPGC 0.22
- SLRX 0.14
- MACD
- SPGC 0.03
- SLRX -0.09
- Stochastic Oscillator
- SPGC 31.57
- SLRX 2.80
About SPGC Sacks Parente Golf Inc.
Sacks Parente Golf Inc is a technology-forward golf company, with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related products. It designs, manufactures, and sells technology-forward, golf equipment, which is comprised of putting instruments, golf shafts, golf grips, and related product groups. It designs its golf products to fit golfers of all skill levels, amateur and professional. Its business segments currently include, golf putting instruments, golf shafts, and golf related products.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.